XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Interim Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Research and development $ (1,617) $ (1,706)
General and administrative (1,302) (1,470)
Operating loss (2,919) (3,176)
Financing income (expenses), net 66 (13)
Net loss $ (2,853) $ (3,189)
Basic and diluted net loss per share $ (0.36) $ (0.45)
Basic and diluted weighted average common shares outstanding 8,013,295 7,108,133